News & Media

A California biotech has leveraged artificial intelligence and other cutting-edge tools in a perilous rescue mission focused on a 2-year-old Setauket boy born with an unusual genetic disease.

Two years ago, Yiwei She was searching desperately for someone to build a drug for her newborn son, Leo. Leo was born with a very small head, a symptom of many severe diseases. After a seizure at two months, doctors sequenced his genome and found a single misspelling in a gene called TNPO2.